IVHEM
Meeting category
Date(s)
2 Dec 2016 - 3 Dec 2016
Location
Amsterdam, Netherlands
Organizer
Titanium Level Support
Sponsor logos
Gilead logo

International Viral Hepatitis Elimination Meeting (IVHEM) 2016

Related Enduring Materials

Enduring Materials

Day 1 - Friday, 2 December 2016

-
Opening lecture on WHO programs
Gottfried Hirnschall
Gottfried Hirnschall, MD, MPH
World Health Organization, USA
Session 1: Results of National programs: Barriers & Successes -
National perspectives in Europe - common themes and challenges
Angelos Hatzakis, MD, PhD, MSc
Athens University Medical School, Greece
National Programs - the Netherlands
Anouk Urbanus
Anouk Urbanus
National Institute of Public Health and the Environment, Bilthoven, the Netherlands
National Programs - Egypt
Wahid Doss
Wahid Doss, MD
National Committee for Control of Viral Hepatitis, Egypt
National Programs - Australia
National Programs - US
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Session 2: Progress towards elimination - Specific Populations -
Progress towards elimination in the Australian prison sector
Andrew Lloyd
Andrew Lloyd, MBBS, MD, FRACP, PhD
Kirby Institute, University of New South Wales, and Justice Health & Forensic Mental Health Network, Australia
Children & Pregnant women
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
People who inject drugs
Olav Dalgard
Olav Dalgard
University Hospital, Norway

Day 2 - Saturday, 3 December 2016

Session 3: Diagnosing -
WHO Guidelines and Policies of testing
Progess in testing technologies
Dmytro Donchuk
Dmytro Donchuk
Médecins Sans Frontières, Belgium
Challenges in Monitoring (POC)
Isabelle Andrieux-Meyer
Isabelle Andrieux-Meyer
O.A.S.I.S. Clinic, Oakland, CA, USA
Challenges in regards to resistance
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Session 4: Reducing Transmission and harm -
Global Injection Safety Campaign and Prevention Strategies
Arshad Altaf
Arshad Altaf, MD, MBBS
Burnet Institute, Australia
Can we afford not to treat reinfection
Peter Vickerman
Peter Vickerman
University of Bristol, United Kingdom
Creating awareness and sharing the knowledge
Anya Sarang
Anya Sarang
Andrey Rylkov Foundation for Health and Social Justice, Russia
Community and harm reduction response to infection and reinfection
Eberhard Schatz
Eberhard Schatz
Correlation Network c/o Foundation De Regenboog Groep, the Netherlands
Session 5: Future scenarios for elimination -
Vaccine development and results
Andrea Cox, MD
Johns Hopkins School of Medicine, United States
Minimising treatment duration and doses
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease, Canada
Role of generic drugs
Andrew Hill
Andrew Hill, MD
Liverpool University, UK
Financial models for high- and low income countries
Pieter Walhof
Pieter Walhof
PharmAccess Foundation, the Netherlands
Building global capacity
Stefano Vella
Stefano Vella
Istituto Superiore di Sanità
Overview
Welcome

IVHEM 2016 welcomed almost 120 passionate participants from 26 different countries. The Organizing Committee would like to thank all invited speakers and participants for their contribution to this workshop!

We would also like to thank our sponsors Gilead, MSD and Siemens Healthineers, for making this event possible and our endorsers for their support.

Practical Information

Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop.
Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio and Video Recording
We do not permit recordings of official meeting sessions either via photograph or other audio/video recording devices. Only the official medical writer appointed by the organization may make recordings.
Committees
Organizing Committee

The members of the Organizing Committee (OC) discuss on a frequent basis the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

6 yearly rotating members of the Organizing Committee form the Program Committee (PC), which is responsible for day-to-day decisions.

Program Committee
Organizing Committee
Henry Lik Yuen Chan
Henry Chan, MD, FRCP, FAASLD, FHKCP, FHKAM, MBChB
The Chinese University of Hong Kong, China
Rafael Esteban
Rafael Esteban, MD
Hospital Universitario Val d’Hebron, Spain
Graham Foster
Graham Foster, FRCP, PhD
University of London, UK
Heiner Wedemeyer
Heiner Wedemeyer, MD
University Clinic Essen, Germany
Support
Titanium Level
Contributor Level
Support
Endorsers
Language